• 0 Posts
  • 319 Comments
Joined 8 months ago
cake
Cake day: March 31st, 2025

help-circle

















  • fullsquare@awful.systemstoScience Memes@mander.xyzInsulin
    link
    fedilink
    English
    arrow-up
    4
    ·
    8 days ago

    i mean i don’t think about it as a separate budget line because if you don’t have that you get police raids and investigation instead of normal business, but yea. insulin is purified using HPLC, so at all times you get some of analytical data about fractions you just made, so some of QC, not all, but already something, already happens at this point

    my point is that actual manufacturing costs will be low because biotech scalability logic is that you need to make yeast or something that makes peptide you like and then all you need to do is keep bioreactor alive and happy. lots of what is left is in purification

    also it’s an injectable so it’s gonna be kept to some standards that non-injected drugs aren’t. whoever comes up with insulin pill will be printing money


  • fullsquare@awful.systemstoScience Memes@mander.xyzInsulin
    link
    fedilink
    English
    arrow-up
    3
    ·
    edit-2
    8 days ago

    there are multiple short-acting and long-acting insulins because you can’t patent other people’s things, but now it’s all off-patent. just take your stainless steel bioreactor and preparative HPLC, cook up a batch, wait ten years for biosimilar approval and you’re good to go

    because unlike with small molecule drugs, when cooking up generic biopharmaceutical there’s extra approval process that amounts to a tiny clinical trial https://en.wikipedia.org/wiki/Biosimilar this and type of economics of scale that there is with biologicals makes manufacture at large scale way more preferable. these requirements were loosened a bit over time